Evidence map›Paper›PMID 36522727›Full record

ArticleMalaria journal2022

Countrywide insecticide resistance monitoring and first report of the presence of the L1014S knock down resistance in Niger, West Africa.

Hadiza Soumaila, Boubé Hamani, Ibrahim Issa Arzika, Amadou Soumana, Abdoulaye Daouda, Fatoumata Abdoulaye Daouda, Souleymane Mahaman Iro, Samira Gouro, Maman Sani Zaman-Allah, Izamné Mahamadou and 17 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Burden of Malaria in Adults in Sahelian Niger: A Retrospective Study (2019-2021).The American journal of tropical medicine and hygiene · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Hadiza SoumailaPMI VectorLink Project, Niamey, Niger.
Boubé HamaniNational Malaria Control Programme, Niamey, Niger.
Ibrahim Issa ArzikaCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Amadou SoumanaCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Abdoulaye DaoudaNational Malaria Control Programme, Niamey, Niger.
Fatoumata Abdoulaye DaoudaNational Malaria Control Programme, Niamey, Niger.
Souleymane Mahaman IroCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Samira GouroNational Malaria Control Programme, Niamey, Niger.
Maman Sani Zaman-AllahNational Malaria Control Programme, Niamey, Niger.
Izamné MahamadouCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Saadou KadriCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Noura Maman SaléCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Wilfried HounkanrinCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Boubacar MahamadouCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Halima Naroua ZamakaCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Rabiou LabboCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Ibrahim Maman LaminouCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Hadiza JackouNational Malaria Control Programme, Niamey, Niger.
Sabiti IdrissaNational Malaria Control Programme, Niamey, Niger.
Eric CoulibalyU.S. President's Malaria Initiative, USAID, Niamey, Niger.
Zilahatou Bahari-TohonU.S. President's Malaria Initiative, USAID, Niamey, Niger.
Els MathieuU.S. President's Malaria Initiative, USAID, Niamey, Niger.
Jenny CarlsonEntomology Branch, U.S. President's Malaria Initiative, Atlanta, GA, USA.
Ellen DotsonU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Taiwo Samson AwololaU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cecilia FlatleyPMI VectorLink Project, Washington, DC, USA.
Joseph ChabiPMI VectorLink Project, Washington, DC, USA. Joseph_Chabi@pmivectorlink.com.
Centre de Recherche Médicale et Sanitaire · NENational Hospital Niamey · NECenters for Disease Control and Prevention · USVector (United States) · USUnited Nations Children's Fund Niger · NEU.S. President's Malaria Initiative · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMass distribution of insecticide-treated nets (ITNs) is the principal malaria vector control strategy adopted by Niger. To better inform on the most appropriate ITN to distribute, the National Malaria Control Programme (NMCP) of Niger and its partners, conducted insecticide resistance monitoring in selected sites across the country.

methodsThe susceptibility of Anopheles gambiae sensu lato (s.l.) to chlorfenapyr and pyrethroid insecticides was investigated in a total of sixteen sites in 2019 and 2020, using 2-5-day-old adults reared from wild collected larvae per site. The susceptibility status, pyrethroid resistance intensity at 5 and 10 times the diagnostic concentrations, and piperonyl butoxide (PBO) synergism with diagnostic concentrations of deltamethrin, permethrin and alpha-cypermethrin were assessed using WHO bioassays. Two doses (100 and 200 µg/bottle) of chlorfenapyr were tested using the CDC bottle assay method. Species composition and allele frequencies for knock-down resistance (kdr-L1014F and L1014S) and acetylcholinesterase (ace-1 G119S) mutations were further characterized using polymerase chain reaction (PCR).

resultsHigh resistance intensity to all pyrethroids tested was observed in all sites except for alpha-cypermethrin in Gaya and Tessaoua and permethrin in Gaya in 2019 recording moderate resistance intensity. Similarly, Balleyara, Keita and Tillabery yielded moderate resistance intensity for alpha-cypermethrin and deltamethrin, and Niamey V low resistance intensity against deltamethrin and permethrin in 2020. Pre-exposure to PBO substantially increased susceptibility with average increases in mortality between 0 and 70% for tested pyrethroids. Susceptibility to chlorfenapyr (100 µg/bottle) was recorded in all sites except in Tessaoua and Magaria where susceptibility was recorded at the dose of 200 µg/bottle. Anopheles coluzzii was the predominant malaria vector species in most of the sites followed by An. gambiae sensu stricto (s.s.) and Anopheles arabiensis. The kdr-L1014S allele, investigated for the first time, was detected in the country. Both kdr-L1014F (frequencies [0.46-0.81]) and L1014S (frequencies [0.41-0.87]) were present in all sites while the ace-1 G119S was between 0.08 and 0.20.

conclusionThe data collected will guide the NMCP in making evidence-based decisions to better adapt vector control strategies and insecticide resistance management in Niger, starting with mass distribution of new generation ITNs such as interceptor G2 and PBO ITNs.

Indexed as

AnophelesInsecticidesMalariaPyrethrinsAcetylcholinesteraseAfrica, WesternAnimalsChlorphentermineInsecticide ResistanceMosquito VectorsNigerNitrilesPermethrinAcetylcholinesterasechlorfenapyrChlorphenterminecypermethrindecamethrinInsecticidesNitrilesN-methylchlorphenterminePermethrinPyrethrinsInsecticide resistanceMalariaNew generation ITNsNigerResistance mechanisms

Identifiers

PMID36522727
PMCPMC9756763
OpenAlexW4311927068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.